Rare Disease Diagnostics Market to Reach USD 80.1 billion by 2033 Market Summary: As per our latest research, the global rare disease diagnostics market size in 2024 stands at USD 34.6 billion, exhibiting robust momentum with a CAGR of 9.8% expected from 2025 to 2033. Fueled by advancements in genomics, molecular diagnostics, and increased awareness among healthcare professionals, the market is forecasted to reach USD 80.1 billion by 2033. This growth trajectory is underpinned by the rising prevalence of rare diseases, substantial investments in research and development, and the integration of cutting-edge technologies into clinical practice, making rare disease diagnostics a pivotal segment within the broader healthcare diagnostics landscape. Challenges in Rare Disease Diagnostics Despite advancements, several hurdles remain: • Limited awareness among healthcare professionals • High costs of advanced diagnostic tests • Lack of standardized testing protocols • Insufficient access to genetic counseling in some regions Future Outlook The future of rare disease diagnostics lies in personalized medicine and global collaboration. As genetic testing becomes more affordable and accessible, and as AI systems continue to learn, the time required for diagnosis will shorten dramatically. Continued investments in research and awareness campaigns will further accelerate progress. Source: https://researchintelo.com/report/rare-disease-diagnostics-market